Caprion (Canada)

Recent papers from Caprion (Canada)

1. Powering Neurology Drug Development Trials to Reduce False Negative ResultsClinical and Translational Science · 2026
2. Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 studyThe Lancet Microbe · 2024
3. Retinoic Acid Boosts HIV-1 Replication in Macrophages via CCR5/SAMHD1-Dependent and mTOR-Modulated Mechanisms2023
4. Recommendations on qPCR/ddPCR Assay Validation by GCCBioanalysis · 2022
5. Recommendations on ELISpot Assay Validation by the GCCBioanalysis · 2022
6. Best practices for the development and fit-for-purpose validation of biomarker methods: a conference reportAAPS Open · 2022
7. IL-17A reprograms intestinal epithelial cells to facilitate HIV-1 replication and outgrowth in CD4+ T cellsiScience · 2021
8. Brief Report: Subclinical Carotid Artery Atherosclerosis Is Associated With Increased Expression of Peripheral Blood IL-32 Isoforms Among Women Living With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes · 2021
9. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's diseaseAlzheimer s & Dementia · 2021
10. Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical AtherosclerosisFrontiers in Immunology · 2021
11. LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapyEBioMedicine · 2021
12. IL-10 driven memory T cell survival and Tfh differentiation promote HIV persistence2021
13. Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modificationAlzheimer s & Dementia · 2021
14. Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analysesCytometry Part B Clinical Cytometry · 2020
15. Best practices for optimization and validation of flow cytometry‐based receptor occupancy assaysCytometry Part B Clinical Cytometry · 2020
16. Flow cytometric method transfer: Recommendations for best practiceCytometry Part B Clinical Cytometry · 2020
17. High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare eventsCytometry Part B Clinical Cytometry · 2020
18. Pharmacological Inhibition of PPARy Boosts HIV Reactivation and Th17 Effector Functions, while Preventing Progeny Virion Release and de novo InfectionPathogens and Immunity · 2020
19. Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity PredictionFrontiers in Immunology · 2020
20. Improving HIV Outgrowth by Optimizing Cell-Culture Conditions and Supplementing With all-trans Retinoic AcidFrontiers in Microbiology · 2020